POM-V Prescription Required Companion Animal

Clindaseptin 25 mg/ml Oral Solution for Cats & Dogs

Active ingredient: Clindamycin

Form

Liquid

Species

Cats Dogs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/4032

What it's used for

Cats: For the treatment of infected wounds and abscesses caused by clindamycin- sensitive species of Staphylococcus spp. and Streptococcus spp. Dogs: - cau...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clindamycin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Clindaseptin 25 mg/ml Oral Solution for Cats & Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 18 Mar 2026.

Cats:
For the treatment of infected wounds and abscesses caused by clindamycin-
sensitive species of Staphylococcus spp. and Streptococcus spp.
Dogs:
-
caused by or associated with clindamycin-sensitive species of Staphylococcus
spp., Streptococcus spp., Bacteroides spp., Clostridium perfringens,
Fusobacterium necrophorum.
-
treatment of infections of the gingival and periodontal tissues.
-Staphylococcus aureus.

Revised: January 2017
AN: 00753/2016

For oral administration only.
To ensure administration of a correct dose, body weight should be determined as
accurately as possible.
Recommended dosage:
Cats:

Revised: January 2017
AN: 00753/2016
-
5.5 mg/kg per 12h for 7 to 10 days
The treatment should be stopped if no therapeutic effect is observed after 4 days.
Dogs:
-
per kg of body weight per 24h or 5.5 mg/kg per 12h for 7 to 10 days.
The treatment should be stopped if no therapeutic effect is observed after 4 days.
-
weight every 12 hours during a period of 28 days minimum. The treatment should
be discontinued if no therapeutic effect is observed in the first 14 days.
DosageVolume to be administered per kg
bodyweight
5.5 mg/kgCorresponding approximately to 0.25 ml per
kg
11 mg/kgCorresponding approximately to 0.5 ml per
kg
A 3 ml graduated syringe is provided to facilitate the administration of the veterinary
medicinal product.

Do not use in rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants
because ingestion of clindamycin by these species may cause severe gastro-
intestinal disorders, that can sometimes be fatal.
Do not use in cases of hypersensitivity to either clindamycin or lincomycin, or to any
of the excipients.

In very rare cases, lethargy, vomiting and diarrhoea may be observed.
Clindamycin sometimes causes the overgrowth of non sensitive organisms such as
resistant
be stopped and appropriate measures should be taken based on
clinicalobservations.

Revised: January 2017
AN: 00753/2016
The frequency of adverse reactions is defined using the following convention:
-
course of one treatment)
-
-
-
very rare (less than 1 animal in 10,000 animals, including isolated reports).

None.

Special precautions for use in animals
Inappropriate use of the product may increase the prevalence of bacteria resistant to
clindamycin. Whenever possible, clindamycin should only be used based on
susceptibility testing.
Official national and local antimicrobial policies should be taken into account when
the product is used.
Clindamycin shows parallel-resistance with lincomycin and co-resistance with
erythromycin. There is a partial cross-resistance to erythromycin and other
macrolides.
In case of administration of high doses of clindamycin or during prolonged therapy of
one month or greater, tests for liver and renal functions and blood counts should be
performed periodically.
In dogs and cats with kidney problems and/or liver problems, accompanied by
severe metabolic aberrations, the dose to be administered should be carefully
determined and their condition should be monitored by performing serum tests
during treatment.
The use of the product is not recommended in neonates.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Wash hands after administration.
Persons with known hypersensitivity to lincosamides (lincomycin and clindamycin)
should avoid contact with the veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Other precautions:
None.

This veterinary medicinal product does not require any special storage conditions.

The treatment should be stopped if no therapeutic effect is observed after 4 days.
Dogs:
-
per kg of body weight per 24h or 5.5 mg/kg per 12h for 7 to 10 days.
The treatment should be stopped if no therapeutic effect is observed after 4 days.
-
weight every 12 hours during a period of 28 days minimum. The treatment should
be discontinued if no therapeutic effect is observed in the first 14 days.
DosageVolume to be administered per kg
bodyweight
5.5 mg/kgCorresponding approximately to 0.25 ml per
kg
11 mg/kgCorresponding approximately to 0.5 ml per
kg
A 3 ml graduated syringe is provided to facilitate the administration of the veterinary
medicinal product.
4.10 Overdose (symptoms, emergency procedures, antidotes) (if necessary)
Doses of 300 mg/kg were tolerated by dogs without having adverse effects.
Vomiting, loss of appetite, diarrhoea, leukocytosis and elevations in liver enzymes
(AST, ALT) were observed occasionally. In such cases, discontinue treatment
immediately and establish a symptomatic treatment.
4.11 Withdrawal Period(s)
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.